Mucovit (Acetylcysteine)

Acetylcysteine works by breaking disulfide bonds within the mucopolysaccharide matrix of mucus, which reduces its viscosity and elasticity. The thinner mucus can be cleared more effectively by ciliary action and coughing. Additionally, acetylcysteine serves as a precursor for glutathione, supporting antioxidant defenses in the respiratory epithelium.

The appropriate dose of Mucovit is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Dosage regimens may vary, and the prescriber will provide specific instructions tailored to each individual case.

Safety data for acetylcysteine in pregnancy and lactation are limited. The decision to use Mucovit during pregnancy or while breastfeeding should be made by a qualified healthcare provider after weighing the potential benefits against any possible risks to the mother and the infant.

To order Mucovit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team will provide pricing, availability, shipping details and assist with any required import documentation.

Mucovit’s active ingredient, acetylcysteine, is distinguished by its dual action of reducing mucus viscosity and replenishing intracellular glutathione. Compared with other mucolytics such as carbocisteine or bromhexine, acetylcysteine may offer additional antioxidant benefits, though clinical choice depends on patient-specific factors, tolerability, and physician preference.

Mucovit should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in areas with extreme temperature fluctuations.

Mucovit is administered orally as directed by the prescribing clinician. The dosage form may be a tablet, capsule, or liquid preparation; patients should follow the specific instructions on how to swallow or measure the product, and may be advised to take it with water or food to reduce gastrointestinal discomfort.

Serious adverse reactions, although rare, include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, bronchospasm (particularly in asthmatic individuals), hepatic dysfunction, neutropenia, and angioedema. Patients should seek immediate medical attention if they experience difficulty breathing, rash, swelling, or any signs of an allergic reaction.

Mucovit should be avoided in individuals with a known hypersensitivity to acetylcysteine or any of its excipients. Caution is also advised for patients with severe asthma, uncontrolled hepatic disease, or significant renal impairment, and it should only be used under medical supervision in these populations.